Wanli B. Liu - Publications

Portable Fourier transform infrared spectroscopy method for determining hydrogen chloride in workplace air

Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases

Published: May 25, 2026

Fragrant TRPV3 agonists act as titratable organic adjuvants to amplify antigen-specific IgG response.

Journal: Immunity & inflammation

Published: February 05, 2026

The Role of B Cells in Tumorigenesis and Immunotherapy.

Journal: Immune network

Published: November 22, 2025

The dysregulation of B cells in systemic lupus erythematosus.

Journal: Molecular immunology

Published: October 29, 2025

Autoantibodies induced by Mycoplasma pneumoniae infection underlie the severity of acute lung injury in children.

Journal: Mucosal immunology

Published: October 04, 2025

Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection.

Journal: Nature nanotechnology

Published: August 05, 2025

MDA5 regulates BCR signaling and B-cell function via NF-κB-mediated DNM1.

Journal: Cellular & molecular immunology

Published: February 26, 2025

Author Correction: TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis in Behçet's disease.

Journal: Nature communications

Published: January 03, 2025

Correction to "Discovery of a Covalent Inhibitor of Pro-Caspase-1 Zymogen Blocking NLRP3 Inflammasome Activation and Pyroptosis".

Journal: Journal of medicinal chemistry

Published: November 19, 2024

Discovery of a Covalent Inhibitor of Pro-Caspase-1 Zymogen Blocking NLRP3 Inflammasome Activation and Pyroptosis.

Journal: Journal of medicinal chemistry

Published: August 19, 2024

Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 07, 2024

Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against SARS-CoV-2 or pneumococcal infections.

Journal: Nature biomedical engineering

Published: July 25, 2024